1. Home
  2. TPB vs ANIP Comparison

TPB vs ANIP Comparison

Compare TPB & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Turning Point Brands Inc.

TPB

Turning Point Brands Inc.

HOLD

Current Price

$87.74

Market Cap

1.6B

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$82.10

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TPB
ANIP
Founded
1988
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Tobacco
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
2015
1999

Fundamental Metrics

Financial Performance
Metric
TPB
ANIP
Price
$87.74
$82.10
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$115.00
$110.00
AVG Volume (30 Days)
465.9K
293.3K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
0.39%
N/A
EPS Growth
45.33
419.23
EPS
3.11
1.28
Revenue
$463,062,000.00
$206,547,000.00
Revenue This Year
$13.68
$21.01
Revenue Next Year
$11.32
$17.59
P/E Ratio
$28.31
$65.45
Revenue Growth
28.39
2.47
52 Week Low
$65.80
$62.61
52 Week High
$146.90
$99.50

Technical Indicators

Market Signals
Indicator
TPB
ANIP
Relative Strength Index (RSI) 55.04 48.53
Support Level $83.96 $77.16
Resistance Level $93.44 $83.66
Average True Range (ATR) 4.28 2.64
MACD 0.61 -0.08
Stochastic Oscillator 83.69 39.80

Price Performance

Historical Comparison
TPB
ANIP

About TPB Turning Point Brands Inc.

Turning Point Brands Inc operates as a manufacturer, marketer, and provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum, including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments, namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: